Literature DB >> 3063336

Calmodulin as a target for new chemotherapeutic strategies.

W N Hait1, W T DeRosa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3063336     DOI： 10.3109/07357908809082118

Source DB:  PubMed          Journal:  Cancer Invest        ISSN： 0735-7907            Impact factor:   2.176


× No keyword cloud information.
  2 in total

1.  Suramin and the suramin analogue NF307 discriminate among calmodulin-binding sites.

Authors:  M Klinger; E Bofill-Cardona; B Mayer; C Nanoff; M Freissmuth; M Hohenegger
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

2.  Activity and regulation by growth factors of calmodulin-dependent protein kinase III (elongation factor 2-kinase) in human breast cancer.

Authors:  T G Parmer; M D Ward; E J Yurkow; V H Vyas; T J Kearney; W N Hait
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.